News & Publications

Representation of Luminera Derm in the Sale of its Dermal Business to AbbVie

Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of millions of dollars. Luminera Derm is an R&D company as well as a manufacturer […]

Raz Tepper & Ziv Schwartz & Sharona Haim Pour - Abramovich & Yuval Peled & Ben Strauss & Audrey Abensur & Moran Friedman | Oct 2020 | Transaction

Labor & Employment Legal Update – Bits & Briefs Series – August 2020

In this “Bits & Briefs” chapter of our special series dedicated to Labor and Employment Law, we discuss certain perspectives of engagement of consultants. Please find the full update here

Shay Teken & Moran Friedman & Raz Tepper & Eran Yaniv | Aug 2020 | Legal Update

Legal Update – Hi-Tech; capital markets– March 2020

Representation of Kamada in $25M Private Placement to FIMI Opportunity Funds FBC represented Kamada Ltd. (NASDAQ & TASE: KMDA) in connection with a private placement of $25 million of its ordinary shares to FIMI Opportunity Funds, the leading private equity investor in Israel. The equity offering was made as a private placement of public equity […]

Raz Tepper & Sharon Rosen & Yuval Peled & Garance Seroussi | Mar 2020 | Transaction

Bits & Briefs – Labor Update – January 2020

In our “Bits & Briefs” Special Series dedicated to Israeli Labor and Employment Law, we provide periodic bite-sized updates introducing key provisions of Israeli labor law and their practical implications, particularly from the perspective of businesses looking to operate in, or expand to, Israel. In this update we will cover employees` social rights according to the […]

Moran Friedman & Raz Tepper & Shay Teken & Eran Yaniv | Feb 2020 | Legal Update

Incorporation of Surround Ventures – a New Venture Capital Fund

Representation of the general partner in the incorporation of Surround Ventures, a new venture capital fund, which will be focused in making investments in early stage companies in the field of media and entertainment. The fund, backed by Randi Zuckerberg, founder of Zuckerberg Media and sibling of Mark Zuckerberg, is raising a $35,000,000 fund to […]

Raz Tepper & Shmulik Fried | Dec 2019 | Transaction

Representation of AngioDynamics in the acquisition of Eximo Medical

FBC and DLA Piper represented AngioDynamics Inc., in an acquisition of Eximo Medical Ltd., an Israeli company. The transaction included extensive and sensitive negotiations of the terms and conditions of the acquisition from the various shareholders of Eximo Medical Ltd. and included the purchase of the company’s shares and treatment of the company’s options and […]

Raz Tepper & Yuval Peled & Jonathan Shtang & Moran Friedman & Omri Rachum-Twaig, Dr. | Oct 2019 | Transaction

Representation of Sky private equity fund in the purchase of Aztek Technologies

FBC represented SKY, a private equity fund, in a transaction for the sale of 100% of the of shares of Aztek Technologies (1984) Ltd. The consummation of the transaction is subject, among others, to the approval of the Israel Competition Authority. Aztek is one of the few distributors and resellers of Microsoft’s products including the […]

Raz Tepper | Sep 2019 | Transaction

Representation of SKY private equity fund in the sale of Marmanet

FBC represented SKY, a private equity fund, in a transaction for the sale of 100% the of shares of Marmanet Organization and Projects Management Ltd., for a consideration of NIS 97M (assuming a distribution of dividends to Marmanet’s shareholders of NIS 5M). Marmanet is a company that manages and operates outsourcing projects for the public […]

Raz Tepper | Mar 2019 | Transaction

Representation of Bristol-Myers Squibb Company in its $12M Investment in Compugen Ltd.

FBC represented Bristol-Myers Squibb Company (NYSE: BMY) in connection with its $12M equity investment in Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery. The equity offering was made as a private placement of public equity (PIPE). The equity investment is being made in conjunction with a clinical trial […]

Raz Tepper & Sharon Rosen | Oct 2018 | Transaction

Legal Update: Hi-Tech, Technology & Venture Capital – IIA New Licensing Rules – October 2018

New Licensing Rules by the Israeli Innovation Authority for Multinational Corporations At the beginning of September, the Israeli Innovation Authority, a division of the Israeli Ministry of Economy and Industry and the successor to the Office of Chief Scientist (“IIA”), issued new rules (“New Rules”) regarding the licensing of know-how developed and obtained by Israeli […]

Raz Tepper | Oct 2018 | Legal Update

Represented of Gestetnertec Ltd. in the purchase of shares of Caliber Engineering and Computers Ltd.

FBC represented Gestetnertec Ltd., owned by SKY private equity fund, in a transaction for the purchase of 70% the of shares of Caliber Engineering and Computers Ltd., which is one of the leading companies in the field of distributing and sales of 3D printers of various kinds. The transaction included extensive and sensitive negotiations of […]

Raz Tepper | Jun 2018 | Transaction

Representation of Twine Solutions in a financing round of US $5,000,000

FBC represented Twine Solutions Ltd. in an equity financing round, led by Landa Ventures Ltd., managed by Benny Landa. As part of the financing round, Twine raised an aggregate amount of USD$7,285,000 from Landa, Gefen Capital Investments L.P. and other investors, in consideration for issuance of Series B-3 Preferred Shares. Twine is a technology start-up, […]

Raz Tepper | Dec 2017 | Transaction

FBC represented SKY and Kedman Capital in the purchase of 70% of S.AL Holdings Ltd.

FBC represented the SKY and Kedma Capital private equity funds in a transaction for the purchase of 70% of the shares of S.AL Holdings Ltd., in consideration of approximately NIS 136.5M. The consummation of the transaction is subject to the approval of the Israel Antitrust Authority. S.AL Holdings, a leading company in the field of […]

Raz Tepper & Michael Zellermayer & Ziv Schwartz | Jul 2017 | Transaction

FBC represented OrbiMed in its $5,325,000 investment in MobileODT

FBC represented OrbiMed in its $5,325,000 investment in MobileODT Ltd. as part of a Series B Round of approximately $6,825,000 investment, in addition to conversion of SAFEs (“simple agreement for future equity”) in the amount of $3,905,223. The transaction included complex questions with regard to the applicability of the Israeli Securities Law and IP. MobileODT […]

Raz Tepper & Shmulik Fried | Jul 2017 | Transaction

Legal Update: Hi-Tech, Technology & Venture Capital – June 2017

Click here to view the full update New Rules Published by the Israeli Innovation Authority In May 2017, the Israeli Innovation Authority (the successor of the Office of Chief Scientist), a division of the Israeli Ministry of Economy and Industry (the “Innovation Authority”), issued new rules[1] becoming applicable to Israeli companies that receive grants from […]

Raz Tepper & Shmulik Fried | Jun 2017 | Legal Update

Israel: Cross Border Joint Venture and Strategic Alliance Guide (LexisNexis)

‘Lexis Practice Advisor’ published an Israel Cross Border Joint Venture and Strategic Alliance Guide. FBC Partner Raz Tepper wrote one of the articles. Please click here to read the full article. Please click here to read the article in Chinese.

Raz Tepper | Apr 2017 | Publication

FBC represented QUALCOMM, in its $5 Million investment in Prospera Technologies Ltd

FBC represented QUALCOMM Ventures, in leading a $5 Million investment in Prospera Technologies Ltd., as part of a Series B round of $15 Million. The other investors included Bessemer Venture Partners, Cisco Investments BV and others. QUALCOMM, traded on Nasdaq, is a global leader in research, development, manufacture and marketing of wireless telecommunications products and […]

Raz Tepper & Shmulik Fried | Mar 2017 | Transaction

FBC represented Twine Solutions Ltd. in a financing round of US $3,500,000

FBC represented Twine Solutions Ltd. in an equity financing round, led by Gefen Capital Investments L.P. As part of the financing round, Twine raised an aggregate amount of USD$ 2,390,000 from Gefen and from additional investors, in consideration for issuance of Series B Preferred Shares, and convertible loans previously granted to the company, in an […]

Raz Tepper | Mar 2017 | Transaction

Investment in MediaSafe Project Ltd.

FBC acted as Israeli counsel to Octopus Ventures, who was the lead investor in the financing round of $14.5 million of MediaSafe Project Ltd., an Israeli company whose primarily business is in the healthcare IT field. For press, click here

Raz Tepper & Shmulik Fried | Feb 2017 | Transaction

FBCrepresented Rel-Tech Holdings and Coin Ventures Ltd. in an investment round of USD 6M in Comedy Technologies, Inc.

Our firm represented Rel-Tech Holdings and Coin Ventures Ltd. (the “Rhodium Group”) in an investment round in which Comedy Technologies, Inc. raised USD 6M from Wicklow Corporation, Pearl Ridge Capital, Gigi Levi, the Rhodium Group and other investors. As part of the investment round USD 1.5M were invested and convertible loans previously granted to the company, […]

Raz Tepper | Sep 2016 | Transaction

FBC represented Applied Immune Technologies Ltd. in a complex merger transaction

FBC represented Applied Immune Technologies Ltd. (“AIT”), a drug development company specializing in therapeutic applications for cancer and other autoimmune diseases, owned by Technion Research and Development Foundation Ltd., Technion Investment Opportunities Fund, OrbiMed Israel Partners Limited Partnership, Novartis Bioventures Ltd., Pontifax funds and others, in a complex merger transaction for the purchase and sale […]

Raz Tepper & Ron Sitton | Jan 2016 | Transaction

FBC advises the OrbiMed Fund in an investment in AtoxBio

FBC advises Orbimed in an investment in Atox Bio, a clinical stage company which develops novel immune-modulators for severe infections.

Raz Tepper | Aug 2014 | Transaction

FBC advises Qualcomm in its acquisition of Wilocity for approximately $400M

Raz Tepper & Moran Friedman | Jul 2014 | Transaction

FBC advises Qualcomm in its acquisition of CSR’s imaging unit for approximately $45M

Raz Tepper & Ronald Lehmann & Amit Dat & Moran Friedman & Ziv Schwartz | Jul 2014 | Transaction

FBC advises the OrbiMed Fund in an investment in Nucleix

FBC advises Orbimed in an investment in Nucleix, which develops a test for early detection of bladder cancer.

Raz Tepper | May 2014 | Transaction

FBC advises the Orbimed Fund in an investment in Keystone Heart

FBC advises Orbimed in an investment in Keystone Heart, which develops and manufactures embolic cerebral protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.